Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : indonesian journal of medical laboratory science and technology

UREUM AND CREATININE HEALTH STUDY IN PATIENTS DIABETES MELLITUS Kurniawan, Muhammad Rizki; Kusrini, Eni
JURNAL INDONESIA DARI ILMU LABORATORIUM MEDIS DAN TEKNOLOGI Vol 2 No 2 (2020): Increasing Research in Diagnostic Laboratory Testing
Publisher : Universitas Nahdlatul Ulama Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/ijmlst.v2i2.1565

Abstract

Diabetes mellitus is a metabolic disease that is marked by an increase in blood glucose levels exceeds normal limits. One of the effects of diabetes mellitus is kidney function disorder. Many researches about diabetes mellitus found that patients have uncontrolled levels of urea and creatinine. The purpose of this study was to determine urea and creatinine levels in patients with diabetes mellitus. The research method uses a descriptive approach to determine urea and creatinine levels among diabetes mellitus patients. The results of this study based on the participant characteristics were 47.3% male respondents and 52.7% female respondents, then based on diabetic aged >45 years was 90.95% and <45 years 9.1%. Based on disease duration, illness for five years was 65.5%, 6-10 years 16.3% and >10 years was 18.2%. The overall creatinine and urea levels were normal. The conclusion of this study is a general description of urea and creatinine levels in the study sample within normal limits. However, the age factor of patients less than 45 years and the duration of illness from 6 to 10 years has a risk of increased levels of urea and creatinine in the blood.
Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients Yorike, Dela; Kurniawan, Muhammad Rizki; Syafaat, Mohamad
JURNAL INDONESIA DARI ILMU LABORATORIUM MEDIS DAN TEKNOLOGI Vol 4 No 1 (2022): The future of diagnostic laboratory testing
Publisher : Universitas Nahdlatul Ulama Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/ijmlst.v4i1.2487

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Coronavirus is a dangerous pathogen that affects both humans and animals. Symptoms and indicators of COVID-19 infection include fever, cough, and shortness of breath, which are common in respiratory illnesses. COVID-19 has spread globally with high mortality and morbidity rates. Prothrombin Time (PT), Activated Prothrombin Thromboplastin (APTT), and D-Dimer parameters are blood tests to evaluate the coagulation status of COVID-19 patients, all these parameters increased in COVID-19 patients. This study aims at determininig the levels of D-Dimer, PT, and APTT in COVID-19 patients. Clinical and laboratory records were retrospectively reviewed from 100 cases of COVID-19 admitted to hospitals. This study used a a cross-sectional, descriptive, secondary data analysis design. The sample included patients from the Bhayangkara TK. I R.Said Sukanto Hospital between April-July 2021. The sample is a COVID-19 patient who was treated in the Intensive Care Unit (ICU), worsened, and given heparin. An independent variable is the administration of intravenous heparin at prophylactic doses. Dependent variables are D-Dimer, PT, and APTT values. The collected data is processed using Microsoft Office Excel and then being analyzed. D-Dimer, PT, and APTT levels in COVID-19 patients were initially high or increased after heparin administration decreased or became normal. In conclusion, there was a decrease in D-dimer levels, PT values, and APTT after administration of intravenous heparin at prophylactic doses.